These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

780 related items for PubMed ID: 17108316

  • 1. Early embryonic renal tubules of wild-type and polycystic kidney disease kidneys respond to cAMP stimulation with cystic fibrosis transmembrane conductance regulator/Na(+),K(+),2Cl(-) Co-transporter-dependent cystic dilation.
    Magenheimer BS, St John PL, Isom KS, Abrahamson DR, De Lisle RC, Wallace DP, Maser RL, Grantham JJ, Calvet JP.
    J Am Soc Nephrol; 2006 Dec; 17(12):3424-37. PubMed ID: 17108316
    [Abstract] [Full Text] [Related]

  • 2. Ouabain Regulates CFTR-Mediated Anion Secretion and Na,K-ATPase Transport in ADPKD Cells.
    Jansson K, Venugopal J, Sánchez G, Magenheimer BS, Reif GA, Wallace DP, Calvet JP, Blanco G.
    J Membr Biol; 2015 Dec; 248(6):1145-57. PubMed ID: 26289599
    [Abstract] [Full Text] [Related]

  • 3. Mouse cystic fibrosis transmembrane conductance regulator forms cAMP-PKA-regulated apical chloride channels in cortical collecting duct.
    Lu M, Dong K, Egan ME, Giebisch GH, Boulpaep EL, Hebert SC.
    Proc Natl Acad Sci U S A; 2010 Mar 30; 107(13):6082-7. PubMed ID: 20231442
    [Abstract] [Full Text] [Related]

  • 4. CFTR mediated chloride secretion in the avian renal proximal tubule.
    Laverty G, Anttila A, Carty J, Reddy V, Yum J, Arnason SS.
    Comp Biochem Physiol A Mol Integr Physiol; 2012 Jan 30; 161(1):53-60. PubMed ID: 21964154
    [Abstract] [Full Text] [Related]

  • 5. The relationship between cell proliferation, Cl- secretion, and renal cyst growth: a study using CFTR inhibitors.
    Li H, Findlay IA, Sheppard DN.
    Kidney Int; 2004 Nov 30; 66(5):1926-38. PubMed ID: 15496164
    [Abstract] [Full Text] [Related]

  • 6. Cystic fibrosis transmembrane conductance regulator (CFTR) and renal function.
    Stanton BA.
    Wien Klin Wochenschr; 1997 Jun 27; 109(12-13):457-64. PubMed ID: 9261986
    [Abstract] [Full Text] [Related]

  • 7. Cross talk of cAMP and flavone in regulation of cystic fibrosis transmembrane conductance regulator (CFTR) Cl- channel and Na+/K+/2Cl- cotransporter in renal epithelial A6 cells.
    Niisato N, Nishino H, Nishio K, Marunaka Y.
    Biochem Pharmacol; 2004 Feb 15; 67(4):795-801. PubMed ID: 14757180
    [Abstract] [Full Text] [Related]

  • 8. Small-molecule CFTR inhibitors slow cyst growth in polycystic kidney disease.
    Yang B, Sonawane ND, Zhao D, Somlo S, Verkman AS.
    J Am Soc Nephrol; 2008 Jul 15; 19(7):1300-10. PubMed ID: 18385427
    [Abstract] [Full Text] [Related]

  • 9. cAMP-dependent chloride secretion mediates tubule enlargement and cyst formation by cultured mammalian collecting duct cells.
    Montesano R, Ghzili H, Carrozzino F, Rossier BC, Féraille E.
    Am J Physiol Renal Physiol; 2009 Feb 15; 296(2):F446-57. PubMed ID: 19052103
    [Abstract] [Full Text] [Related]

  • 10. cAMP inhibition of murine intestinal Na/H exchange requires CFTR-mediated cell shrinkage of villus epithelium.
    Gawenis LR, Franklin CL, Simpson JE, Palmer BA, Walker NM, Wiggins TM, Clarke LL.
    Gastroenterology; 2003 Oct 15; 125(4):1148-63. PubMed ID: 14517798
    [Abstract] [Full Text] [Related]

  • 11. The chloride channel CFTR is not required for cyst growth in an ADPKD mouse model.
    Talbi K, Cabrita I, Kraus A, Hofmann S, Skoczynski K, Kunzelmann K, Buchholz B, Schreiber R.
    FASEB J; 2021 Oct 15; 35(10):e21897. PubMed ID: 34473378
    [Abstract] [Full Text] [Related]

  • 12. Basolateral chloride transporters in autosomal dominant polycystic kidney disease.
    Lebeau C, Hanaoka K, Moore-Hoon ML, Guggino WB, Beauwens R, Devuyst O.
    Pflugers Arch; 2002 Sep 15; 444(6):722-31. PubMed ID: 12355171
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Pharmacological reversal of renal cysts from secretion to absorption suggests a potential therapeutic strategy for managing autosomal dominant polycystic kidney disease.
    Yanda MK, Cha B, Cebotaru CV, Cebotaru L.
    J Biol Chem; 2019 Nov 08; 294(45):17090-17104. PubMed ID: 31570523
    [Abstract] [Full Text] [Related]

  • 15. The lonidamine derivative H2-gamendazole reduces cyst formation in polycystic kidney disease.
    Sundar SV, Zhou JX, Magenheimer BS, Reif GA, Wallace DP, Georg GI, Jakkaraj SR, Tash JS, Yu ASL, Li X, Calvet JP.
    Am J Physiol Renal Physiol; 2022 Oct 01; 323(4):F492-F506. PubMed ID: 35979967
    [Abstract] [Full Text] [Related]

  • 16. Therapeutic potential of cystic fibrosis transmembrane conductance regulator (CFTR) inhibitors in polycystic kidney disease.
    Li H, Sheppard DN.
    BioDrugs; 2009 Oct 01; 23(4):203-16. PubMed ID: 19697963
    [Abstract] [Full Text] [Related]

  • 17. Expression and regulation of the Na+-K+-2Cl- cotransporter NKCC1 in the normal and CFTR-deficient murine colon.
    Bachmann O, Wüchner K, Rossmann H, Leipziger J, Osikowska B, Colledge WH, Ratcliff R, Evans MJ, Gregor M, Seidler U.
    J Physiol; 2003 Jun 01; 549(Pt 2):525-36. PubMed ID: 12692180
    [Abstract] [Full Text] [Related]

  • 18. An alternate pathway of cAMP-stimulated Cl secretion across the NKCC1-null murine duodenum.
    Walker NM, Flagella M, Gawenis LR, Shull GE, Clarke LL.
    Gastroenterology; 2002 Aug 01; 123(2):531-41. PubMed ID: 12145806
    [Abstract] [Full Text] [Related]

  • 19. cAMP stimulates CFTR-like Cl- channels and inhibits amiloride-sensitive Na+ channels in mouse CCD cells.
    Letz B, Korbmacher C.
    Am J Physiol; 1997 Feb 01; 272(2 Pt 1):C657-66. PubMed ID: 9124310
    [Abstract] [Full Text] [Related]

  • 20. A potential strategy for reducing cysts in autosomal dominant polycystic kidney disease with a CFTR corrector.
    Yanda MK, Liu Q, Cebotaru L.
    J Biol Chem; 2018 Jul 20; 293(29):11513-11526. PubMed ID: 29875161
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 39.